| European Case Law Identifier: | ECLI:EP:BA:2012:T218108.20121114 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 14 November 2012 | ||||||||
| Case number: | T 2181/08 | ||||||||
| Application number: | 01994219.2 | ||||||||
| IPC class: | A61K 38/16 A61K 38/17 A61K 38/18 C07K 14/705 C07K 14/71 C07K 14/715 G01N 33/53 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | TREM-1 splice variant for use in modifying immune responses | ||||||||
| Applicant name: | GenePrint Corporation | ||||||||
| Opponent name: | - | ||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Main and sole request - added matter (no); novelty, inventive step, sufficiency of disclosure, clarity (yes) | ||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t082181eu1.html
Date retrieved: 17 May 2021